Nuclear transport modulators and uses thereof
US10407405B2 · kind B2 · utility
17Cited by
28References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 17, 2017 |
| Grant date | Sep 10, 2019 |
| Priority date | — |
| Expiry date | Jul 17, 2037 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/06
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compounds of formula I: and pharmaceutically acceptable salts thereof, pharmaceutical compositions comprising the compounds of formula I or their pharmaceutically acceptable salts, and methods of using said compounds, salts and compositions in the treatment of various disorders associated with CRM1 activity.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.